Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Hydatidiform Mole, Invasive × Dactinomycin × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Rhabdomyosarcoma 2 Wilms Tumor 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Hydatidiform Mole, Invasive 1 Gestational Trophoblastic Disease 1 Choriocarcinoma 1 Beckwith-Wiedemann Syndrome 1

Interventions

Methotrexate 1 Leucovorin 1 Dactinomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04562558 2025-08-11

Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia

Peking Union Medical College Hospital

Phase NA Active not recruiting

Hydatidiform Mole, Invasive, Choriocarcinoma, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡